✦ LIBER ✦

Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc–MAPK signaling pathway in breast cancer cells

✍ Scribed by Yuhong Lu; Xiaolin Zi; Yunhua Zhao; Michael Pollak

Book ID: 116287692
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 274 KB
Volume: 313
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2003.12.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of ErbB2 by Herceptin reduces

Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2–β-catenin/TCF4-survivin pathway in ErbB2-overexpressed breast cancer cells

✍ Hongxia Zhu; Guo Zhang; Yan Wang; Ninghong Xu; Shun He; Wei Zhang; Meigui Chen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Bidirectional interactions between the e

Bidirectional interactions between the estrogen receptor and the c-erbB-2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells

✍ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/

SUCI02 inhibits the erbB-2 tyrosine kina

SUCI02 inhibits the erbB-2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G1 phase in breast cancer cells

✍ Xiao-Feng Zhu; Jing-Song Wang; Li-Ling Cai; Yi-Xin Zeng; Dajun Yang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Expression of the ErbB4 receptor causes

Expression of the ErbB4 receptor causes reversal regulation of PP2A in the Shc signal transduction pathway in human cancer cells

✍ Noriko Yumoto; Xiaomei Yu; Mariko Hatakeyama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 326 KB

Metformin-mediated growth inhibition inv

Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells

✍ Emelie Karnevi, Katarzyna Said, Roland Andersson, Ann H Rosendahl 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 860 KB

Activation of integrin and ceramide sign

Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines

✍ Perks, C M; Gill, Z P; Newcomb, P V; Holly, J M P 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 612 KB